Introduction: Why TCM Health Products Matter to Natural Supplement Innovators

Demand for natural, plant-based health products continues to grow globally. Alongside that demand, researchers and industry teams are paying closer attention to what actually determines a product's long-term success:

Quality consistency

Safety and toxicology

Mechanism-oriented evidence

Regulatory compliance

Market education and trust-building

In China, Traditional Chinese Medicine (TCM)–related health products are a large and mature category. That makes Chinese academic literature a useful "early signal" system for international developers-especially those evaluating new botanical ingredients such as Cistanche (Rou Cong Rong).

To make this landscape easier to understand, this article summarizes a bibliometric and visual analysis (using CiteSpace) of Chinese literature on "TCM health products" from 2013–2023, and translates the findings into practical insights for Western supplement product development-from basic orientation to deeper R&D strategy.

 

Data Source & Method 

Data source (CNKI, 2013–2023)

The underlying study used the CNKI database (China National Knowledge Infrastructure) and searched with the condition:

Title = "中药保健品" (TCM health products)

Time range: 2013–2023

Non-research items (e.g., brief news, conference notices) were excluded. A total of 296 relevant documents were retained, exported (RefWorks format), and converted into a format compatible with CiteSpace.

 

Method: Bibliometrics + CiteSpace knowledge mapping

The study used bibliometric analysis (quantitative analysis of publication metadata such as authors, institutions, keywords, citations) to reduce subjective interpretation and identify:

Publication patterns and key contributors

Collaboration networks

Knowledge base via highly cited papers

Research hotspots via keyword co-occurrence

Emerging fronts via timeline evolution of keywords

CiteSpace visualizations included:

Keyword co-occurrence networks

Author collaboration networks

Keyword clustering and timeline views

 

1) Research "Geography": Who Is Publishing and How Collaboratively?

Author distribution: no stable "core author group" yet

To identify leading contributors, the study applied a Price's Law approach. In the dataset, the maximum number of papers by a top author over the decade was 4, giving a threshold of roughly 2+ papers for "high-output authors."

20 high-output first authors produced 44 papers

That is ~14.865% of all included papers

Interpretation for developers:

The field is active but still fragmented.

There is no single dominant research school; innovation is distributed.

For ingredient developers (e.g., Cistanche extract), this implies you'll find evidence spread across many teams-useful, but you'll need a structured review process.

Collaboration analysis: "overall dispersed, locally concentrated"

CiteSpace author collaboration networks showed low density with few connecting links.

Interpretation for developers:

Many researchers work in parallel with limited cross-collaboration.

Expect method diversity (different assays, models, endpoints).

When building an international evidence dossier, it's important to standardize:

extract specifications,

outcome definitions,

and safety reporting.

 

Table 1. High-Productivity Authors in TCM Health Product Research (2013–2023)

Author	Publications	Author	Publications	Author	Publications
Li, Li (李莉)	4	Zhang, Jichun (张继春)	2	Ruan, Mei (阮梅)	2
Jin, Pengfei (金鹏飞)	3	Tian, Lan (田兰)	2	Xu, Feng (许凤)	2
Zhang, Honglian (张宏莲)	3	Zhou, Xiaokai (周晓靓)	2	Bao, Zongfang (包综方)	2
Liu, Jicheng (刘吉成)	2	Chu, Zhongying (储忠英)	2	Xu, Qiaoling (徐巧玲)	2
Liu, Wei (刘伟)	2	Li, Jinghui (李静辉)	2	Zhou, Gangwei (周刚卫)	2
Yan, Huifang (严慧芳)	2	Long, Wei (龙伟)	2	Zeng, Xuewen (曾学文)	2
Chen, Rui (陈睿)	2	Xu, Shuo (徐硕)	2

 

2) Knowledge Base: What Foundational Topics Are Most Influential?

Highly cited papers formed the knowledge base and reflected a diverse set of concerns, including:

TCM materia medica (medicinal plant) industry development

Illegal adulteration (adding pharmaceutical chemicals into "health products")

Analytical detection methods (e.g., advanced chromatography–mass spectrometry approaches)

"Big Health" industry context and policy-driven market expansion

Ingredient-focused reviews, such as botanical applications in health products

Interpretation for developers:

China's academic focus is strongly tied to quality & compliance risks (especially adulteration).

For Western audiences, this maps to the same reality:

strong brands win by being transparent, test-driven, and standardized.

 

3) Hotspots: Five Main Research Themes (What the Field Actually Studies)

Keyword analysis and network interpretation summarized the major hotspots into five areas:

(1) Health foods and health outcomes

Research explores:

functional claims,

mechanisms of action,

clinical or quasi-clinical applications,

roles in prevention, recovery support, and health maintenance.

Developer takeaway:
For botanicals like Cistanche extract, product positioning should match measurable outcomes (e.g., energy/fatigue support, healthy aging support) and connect to plausible mechanisms.

(2) Pharmacology and active constituents

Focus includes:

pharmacological actions,

active compounds,

mechanism studies.

Developer takeaway:
This is where ingredient differentiation happens. Western buyers want answers like:

What are the key actives?

How do you standardize them?

What dose range is supported by evidence?

(3) Resource distribution & quality control of herbal materials

Work includes:

identification (authentication),

quality evaluation,

standards and methods.

Developer takeaway:
For global commercialization, this is non-negotiable:

botanical identity and adulteration prevention,

batch-to-batch consistency,

contaminant limits,

traceability.

(4) Safety and regulation

Research covers:

toxicology,

safety assessment,

regulatory policies and compliance.

Developer takeaway:
In Western markets, safety is not a marketing line-it's a documentation system:

specification sheets,

COAs,

stability studies,

heavy metal/pesticide/microbial limits,

and clear label language.

(5) Market development & branding

Includes:

market trend analysis,

branding strategies,

sustainable industry development.

Developer takeaway:
Education-based branding is key. Consumers are curious about "ancient herbs," but trust is earned through:

consistent quality,

credible science summaries,

and responsible claims.

 

4) Keyword Clusters: What the Research Clumps Around

Two major clusters stood out:

"Health foods" (largest cluster; included keywords like "illegal adulteration," "health products," "detection methods")

"TCM category" (a secondary major cluster)

A practical interpretation:

The research ecosystem treats "health products" as both a science problem and a risk management problem.

If you want to introduce a botanical ingredient to Western product developers, leading with quality control and testing strategy will resonate as much as (or more than) tradition stories.

 

Table 2. Most-Cited References (Top 10) in TCM Health Product Research

No.	Title (English translation)	Authors	Source (Journal)	Citations
1	Several reflections on the development of the Chinese medicinal materials industry	Li, Li; Li, Xiaolin; Yang, Guang; Huang, Luli; (et al.)	China Journal of Traditional Chinese Medicine and Pharmacy	60
2	Research progress on illegal adulteration with chemical drugs in traditional Chinese medicines and health products	Xu, Shuo; Jin, Pengfei; Xu, Qiaoling; Lü, Xiaochuan; He, Rongrong	Chinese Journal of New Drugs	34
3	Detection of nine illegally added chemical drugs in sedative and tranquilizing TCM preparations and health products using UHPLC–MS/MS (triple quadrupole)	Tian, Lan; Zhang, Jichun; Chen, Rui; Chu, Zhongying; Bao, Zongfang	China Pharmaceuticals	25
4	Rapid screening of 30 illegally added chemical drugs in weight-loss TCM and health products using LC–MS	Huang, Fang; Wu, Huidong; Zhu, Zibai; Huang, Xiaolan; Luo, Yutai	Journal of Analytical Testing	21
5	A brief analysis of the development of TCM health foods under the "Big Health" industry background	Xing, Chunchun; Hu, Yanjun; Li, Baiqun; Luo, Xiaoqin; Zhong, Liangcai	China Pharmaceuticals	19
6	A review of Astragalus (Huangqi) applications in health products	Liu, Shuangqi; Li, Bingfei; Su, Hui; Zhu, Yunhua	Heilongjiang Science and Technology Information	19
7	Current status and development trends of TCM health products in China	Zhong, Fangfang (钟芳芳)	China Health Industry	19
8	Detection of sulfonylurea antidiabetic drugs illegally added in hypoglycemic TCM and health products using TLC–IR	Zhang, Honglian; Li, Li; Li, Zhi; Liu, Jicheng; Li, Chongchong	Chinese Journal of Pharmaceutical Analysis	14
9	TLC–SERS method for detecting three illegally added PDE5 inhibitors in TCM and health products	Li, Qihong (李启红)	China Modern Medicine	13
10	Detection of sulfonylurea components illegally added in hypoglycemic TCM and health products using thin-layer chromatography	Zhang, Honglian; Li, Li; Xu, Feng; Li, Jinghui; Liu, Jun (刘军)	Science and Technology Innovation Herald	13

5) Emerging Fronts (Recent Years): What's New on the Timeline?

 

The timeline view suggests newer attention toward themes such as:

medication/use patterns (how ingredients/formulas are used)

toxic component measurement (safety analytics)

TCM theory and knowledge inheritance

modern wellness and health maintenance trends

Interpretation for Cistanche extract:

The future is not simply "more herbs," but better-defined herbs:

better standardization,

better mechanism narratives,

clearer safety boundaries,

and more credible evidence summaries.

 

Table 3. Keyword Clusters

Cluster label	Frequency	Other included keywords (English translation)
Health foods (保健食品)	28	Illegal adulteration; health products; sildenafil; detection methods; chemical drugs
TCM category / Chinese medicine (中药类)	22	Health foods; TCM category; health products; TCM health products; health care

 

What This Means for Developing Cistanche (Rou Cong Rong) Extract Products for Western Markets

You asked for a version that helps people "feel the efficacy" of TCM-without slipping into overclaiming. Here's how to do that in a way product developers respect.

Step 1 - Translate tradition into a modern product hypothesis

Instead of saying "TCM works," define a hypothesis developers can test:

Intended use (example): daily vitality support / fatigue support / healthy aging support

Mechanism story: antioxidant pathways, inflammatory signaling modulation, endocrine-adjacent support, etc. (Choose only what you can document.)

Measurable outcomes: validated questionnaires, biomarkers, performance endpoints depending on positioning.

Step 2 - Standardization is your "efficacy amplifier"

Western developers will not commit to an ingredient if they can't reproduce results.

Minimum expectations:

botanical identity authentication (species, part used)

extract ratio, solvent system

marker compounds and specification range

batch COAs

stability plan (shelf life, packaging compatibility)

Step 3 - Make safety legible, not just "claimed"

The CNKI/CiteSpace hotspots show safety and adulteration concerns are central. Use that as your strength:

third-party testing panel (heavy metals, pesticides, PAHs if relevant, microbes)

adulteration screening where appropriate

transparent documentation package (spec sheet + COA template + SDS)

Step 4 - Build your evidence page like a developer-facing dossier

For a Cistanche-focused independent site, consider a "developer" section that includes:

Evidence map (preclinical vs clinical, what endpoints, what doses)

Formulation notes (synergies, stability, taste/odor handling)

Regulatory notes (region-by-region labeling considerations)

Quality control workflow (from raw material to finished extract)

This turns "TCM efficacy" into something a Western team can actually evaluate and integrate into a pipeline.

 

TCM HERB CISTANCHE SUPPLEMENT THAT PERFECT FOR PROSTATE AND KIDNEY 

Conclusions (from the CiteSpace-based Review)

Based on the 2013–2023 CNKI literature set and CiteSpace mapping, the study concluded:

The field has not yet formed a stable core author group, and collaboration is relatively limited.

Highly cited works provide a foundation emphasizing industry development, safety risks (including illegal adulteration), and analytical detection methods, alongside broader "big health" context and ingredient applications.

Research hotspots concentrate around keywords such as health products/health foods, TCM, herbal materials, and extend into pharmacology, quality control, safety/regulation, and market development.

Recent fronts emphasize use patterns, toxic component measurement, TCM, and modern wellness trends-suggesting the next phase is deeper standardization and safety-driven modernization.

 

References

Zhang, Y., Zhang, J., & Zhang, Z. (2018). Research progress in China's agricultural technology-A bibliometric analysis based on CiteSpace. China Science and Technology Forum, (9), 8.

Tan, X., Ouyang, Q., Yu, S., et al. (2017). Knowledge mapping analysis of rural function research in China based on CiteSpace. Economic Geography, 37(10), 7.

Yang, C., Ding, L., & Zhang, J. (2019). Mapping the evolution and frontier hotspots of science and technology resources research based on CiteSpace. Science and Technology Management Research, (3), 8.

Li, Y., Li, X., Yang, G., et al. (2016). Several reflections on the development of China's Chinese medicinal materials industry. China Journal of Traditional Chinese Medicine and Pharmacy, 31(1), 4.

Xu, S., Jin, P., Xu, Q., et al. (2015). Research progress on illegal adulteration with chemical drugs in traditional Chinese medicines and health products. Chinese Journal of New Drugs, 24(16), 8.

Tian, L., Zhang, J., Chen, R., et al. (2013). Detection of nine illegally added chemical drugs in sedative and tranquilizing TCM preparations and health products using UHPLC–MS/MS (triple quadrupole). China Pharmaceuticals, 22(6), 66–68.

Xing, C., Hu, Y., Li, B., et al. (2020). A brief analysis of the development of TCM health foods under the "Big Health" industry background. China Pharmaceuticals, 29(18), 19–21.

Liu, S., Li, B., Su, H., et al. (2016). A review of Astragalus (Huangqi) applications in health products. Scientific and Technological Innovation, 31(6), 75–76.

Luan, C., & Jiang, C. (2008). Status and visualization analysis of SSCI papers published in China in recent years. Information and Documentation Services, (3).

Luo, L., & Yu, Z. (2017). Evolutionary pathways of domestic positive psychology research in China: A CiteSpace-based analysis. Journal of Southwest Minzu University (Humanities and Social Sciences), 38(2), 7.